Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients

Condition:   Cardiac Allograft Vasculopathy Interventions:   Drug: Alirocumab;   Other: Placebo Sponsors:   Institute for Clinical and Experimental Medicine;   St. Anne's University Hospital Brno, Czech Republic;   Centre of Cardiovascular and Transplantation Surgery, Czech Republic Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials